Abbott Point of Care Inc - Product Pipeline Analysis, 2019 Update



Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its products comprise handheld blood analyzers, cardiac markers, lactate, blood gases, electrolytes, lab information systems, electronic medical recording systems, and automated clinical chemistry systems. Abbott Point provides value assignment sheets, software and license keys, tutorial and training materials, and POC testing devices, among others. The company’s services include POC solutions, implementation and training services, technical support services, and laboratory services. It operates in the UK and Canada. Abbott Point is headquartered in Princeton, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Point of Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
 


Abbott Point of Care Inc Company Overview
Abbott Point of Care Inc Company Snapshot
Abbott Point of Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Abbott Point of Care Inc – Pipeline Analysis Overview
Abbott Point of Care Inc - Key Facts
Abbott Point of Care Inc - Major Products and Services
Abbott Point of Care Inc Pipeline Products by Development Stage
Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
Abbott Point of Care Inc Pipeline Products Overview
i-Stat - Traumatic Brain Injury Assay
i-Stat - Traumatic Brain Injury Assay Product Overview
i-Stat - Traumatic Brain Injury Assay Clinical Trial
i-STAT Alinity - Cancer
i-STAT Alinity - Cancer Product Overview
i-STAT Alinity - Infectious Diseases
i-STAT Alinity - Infectious Diseases Product Overview
i-STAT TnI-Nx
i-STAT TnI-Nx Product Overview
Abbott Point of Care Inc - Key Competitors
Abbott Point of Care Inc - Key Employees
Abbott Point of Care Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Abbott Point of Care Inc, Recent Developments
Aug 27, 2019: Study finds Abbott’s blood test could identify mild TBI
May 02, 2019: Abbott forms multidisciplinary alliance to trial blood test for concussions
Apr 30, 2019: Abbott, the U.S. Department of Defense and TRACK-TBI Partner to Study Point-of-Care Blood Test for Concussions
Apr 09, 2018: i-STAT in the Medical Tent
Nov 30, 2016: Abbott Announces CE Mark For i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform
Mar 09, 2016: Abbott, Hennepin County Medical Center and University of Minnesota Collaborate to Launch the Nations Largest, Single-Center Prospective Study on Concussion and Traumatic Brain Injury
Apr 30, 2015: Abbotts First-Of-Its-Kind Blood Test To Aid In Detecting Early Pregnancy Could Help Doctors Make Faster Treatment Decisions For Women
Mar 29, 2011: Abbott Receives FDA Approval For i-STAT 1 Wireless Point Of Care Testing System
Jan 19, 2009: FDA Grants CLIA Waiver To Abbott To Use Five Additional Cartridges On The i-STAT Handheld Blood Analyzer
Apr 10, 2008: MEDRAD To Distribute Abbott’s Portable Blood Analyzer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Abbott Point of Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Abbott Point of Care Inc Pipeline Products by Equipment Type
Abbott Point of Care Inc Pipeline Products by Indication
Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
Abbott Point of Care Inc, Key Facts
Abbott Point of Care Inc, Major Products and Services
Abbott Point of Care Inc Number of Pipeline Products by Development Stage
Abbott Point of Care Inc Pipeline Products Summary by Development Stage
Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
Abbott Point of Care Inc Ongoing Clinical Trials Summary
i-Stat - Traumatic Brain Injury Assay - Product Status
i-Stat - Traumatic Brain Injury Assay - Product Description
i-Stat - Traumatic Brain Injury Assay - Transforming Research and Clinical Knowledge in Traumatic Brain Injury
i-STAT Alinity - Cancer - Product Status
i-STAT Alinity - Cancer - Product Description
i-STAT Alinity - Infectious Diseases - Product Status
i-STAT Alinity - Infectious Diseases - Product Description
i-STAT TnI-Nx - Product Status
i-STAT TnI-Nx - Product Description
Abbott Point of Care Inc, Key Employees
Abbott Point of Care Inc, Other Locations
Glossary
 


List Of Figures


Abbott Point of Care Inc Pipeline Products by Equipment Type
Abbott Point of Care Inc Pipeline Products by Development Stage
Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status "
 


Abbott Full Year Operating Financial

Abbott 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Medical Devices Industry This report is part of the

USD 750 View Report

Abbott 2023 Third Quarter Operating and Financial Review

Abbott 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Medical Devices Industry This report is part of the Competitive

USD 750 View Report

Global Point of Care (PoC) Lipid Test Market Research Report 2021-2025

POC diagnostic devices are used to obtain diagnostic results while with the patient or close to the patient. In the context of China-US trade war and global economic volatility and

USD 3200 View Report

Global Civil and Defence Helicopter Market (Value, Units) – Analysis By Application Type, Point of Sale (OEM, MRO), Weight, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

Executive The Global Civil and Defence Helicopter Market, valued at USD 25.2 billion in the year 2020 has been witnessing unprecedented growth in the last few years on the back

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available